However, majority of the 637 known bacterial, viral, fungal and animal species researchers detected were non-pathogenic and represent normal bacteria present on human skin and human body.
The findings are generally reassuring, indicating no need to avoid the subway system or use protective gloves, said the study's senior investigator, Dr Christopher E Mason, an assistant professor in Weill Cornell's Department of Physiology.
The researchers have demonstrated that it is possible and useful to develop a "pathogen map" - dubbed a "PathoMap" - of a city, with the heavily travelled subway a proxy for New York's population.
These represent organisms that New Yorkers touch every day, but were uncharacterised and undiscovered until this study, researchers said.
"Our data show evidence that most bacteria in these densely populated, highly trafficked transit areas are neutral to human health, and much of it is commonly found on the skin or in the gastrointestinal tract," Mason said.
However, 12 per cent of the bacteria species researchers sampled showed some association with disease. For example, live, antibiotic-resistant bacteria were present in 27 per cent of the samples they collected.
They also detected two samples with DNA fragments of Bacillus anthracis (anthrax), and three samples with a plasmid associated with Yersinia pestis (Bubonic plague) - both at very low levels.
Notably, the presence of these DNA fragments do not indicate that they are alive, and culture experiments showed no evidence of them being alive.
"The presence of these microbes and the lack of reported medical cases is truly a testament to our body's immune system, and our innate ability to continuously adapt to our environment," he said.
The study was published in the journal Cell Systems.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app